14 min
Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. Answers from the Lab
-
- Médecine
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.
(00:31) Could you please provide a little bit about yourself and your background?
(01:30) Would you please share a brief overview of the UBA1Q assay?
(02:13) Would you provide an overview of VEXAS syndrome?
(05:30) When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?
(06:38) What advantage does this assay provide over other methodologies?
(10:13) Could you share further why diagnosis is so important for these patients?
(12:40) Is there anything else you'd like to comment about the assay?
David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.
(00:31) Could you please provide a little bit about yourself and your background?
(01:30) Would you please share a brief overview of the UBA1Q assay?
(02:13) Would you provide an overview of VEXAS syndrome?
(05:30) When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?
(06:38) What advantage does this assay provide over other methodologies?
(10:13) Could you share further why diagnosis is so important for these patients?
(12:40) Is there anything else you'd like to comment about the assay?
14 min